MABVAX THERAPEUTICS HLDGS IN

CUSIP: 55414P504 Class: COM NEW

Cambridge Investment Research Advisors, Inc.'s Holding History (CIK: 0001419186)

Note: Option positions (PUT/CALL) are excluded.

Q4 2017
Shares 3,058,703 Value ($000) $2,141 Avg Close — Range —
Q3 2017
Shares 2,495,203 Value ($000) $1,622 Avg Close — Range —